These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11582958)

  • 1. [Anti-secretory agents modify the gastric localization of Helicobacter pylori].
    Zaterka S
    Arq Gastroenterol; 2001; 38(1):1-2. PubMed ID: 11582958
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 5. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for anti-ulcer drugs in adults].
    Chassany O
    Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
    [No Abstract]   [Full Text] [Related]  

  • 8. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of peptic ulcer in the elderly].
    Koop H
    Z Gerontol; 1992; 25(5):304-8. PubMed ID: 1359717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in ultra rapid urease test and histopathological examination for Helicobacter pylori by antisecretory drugs].
    Ferreira LE; Meirelles GS; Vieira RR; Bragagnolo Júnior MA; Chebli JM; de Souza AF
    Arq Gastroenterol; 2001; 38(1):3-8. PubMed ID: 11586996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 15. Helicobacter pylori eradication--understandable caution but no excuse for inertia.
    de Boer WA
    Aliment Pharmacol Ther; 1995 Feb; 9(1):85-6. PubMed ID: 7766750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 18. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
    Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
    Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
    Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
    J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-helicobacter regimens.
    Harris A; Misiewicz JJ
    Lancet; 1996 Apr; 347(9009):1193-4. PubMed ID: 8609799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.